Unveiling the Complex Interplay: Sudden Emergence of First-Rank Schneiderian Symptoms Following TMS in a Patient With Severe Depression and Complex Trauma.

A case report documents synthetic cannabinoid induced psychosis developing after TMS treatment in a depressed patient. This highlights the need for comprehensive substance screening before neuromodulation therapies. Synthetic cannabinoids pose significant psychiatric risks that may interact dangerously with brain stimulation treatments.

Read More